Consolidated Statement of Shareholders' Equity (Unaudited) - 9 months ended Dec. 31, 2018 - USD ($)	Common Shares [Member]	Additional Paid-In Capital [Member]	Accumulated (Deficit) [Member]	Total
Beginning Balance at Mar. 31, 2018	$ 28,394	$ 17,264,888	$ (7,741,153)	$ 9,552,129
Beginning Balance, shares at Mar. 31, 2018	28,394,503
Common stock issued for cash	$ 2,140	3,588,890		$ 3,591,030
Common stock issued for cash , shares	2,139,886			6,216,083
Common stock issued for exercised warrants	$ 1,973	4,765,652		$ 4,767,625
Common stock issued for exercised warrants , shares	1,972,800
Common stock issued for cashless warrant exercise	$ 11	(11)
Common stock issued for cashless warrant exercise , shares	10,495			10,495
Fund raising cost		(872,870)		$ (872,870)
Common stock issued for services	$ 5	22,345		$ 22,350
Common stock issued for services, shares	5,000			5,000
Acquisition stock issuances	$ 1,700	4,622,305		$ 4,624,005
Acquisition stock issuances, shares	1,700,002			1,700,002
Employee stock awards	$ 437	644,287		$ 644,724
Employee stock awards, shares	437,500
Stock Grants		496,143		496,143
Legal, advisory and consulting fees	$ (50)	(123,950)		(124,000)
Legal, advisory and consulting fees, shares	(49,600)
Net loss for period ended December 31, 2018			(3,973,806)	(3,973,806)
Ending Balance at Dec. 31, 2018	$ 34,610	$ 30,407,679	$ (11,714,959)	$ 18,727,330
Ending Balance, shares at Dec. 31, 2018	34,610,586